18 Followers on Owler
Theravectys
discovers and develops immunotherapies for the prevention and treatment of cancers and other infectious diseaseses...
Theravectys
discovers and develops immunotherapies for the prevention and treatment of cancers and other infectious diseaseses...
News
Apr 19, 2019
BioSpace
Theravectys: NOVASEP and THERAVECTYS Enter Into a New License Agreement on DNA Flap Technology for GMP Manufacturing of Lentiviral Vectors
Oct 22, 2018
BioPortfolio
Theravectys: Theravectys SA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24072018 Prices from USD $250
Aug 04, 2018
BioPortfolio
Theravectys: Theravectys SA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14062018 Prices from USD $250
Nov 06, 2017
BioPortfolio
Theravectys: Theravectys SA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 17102017 Prices from USD $250
Sep 05, 2017
BioPortfolio
Theravectys: Theravectys SA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 22082017 Prices from USD $250
Mar 20, 2017
BioPortfolio
Theravectys: Theravectys SA Pharmaceuticals Healthcare Deals and Alliances Profile Updated 24022017 Prices from USD $250
Jan 19, 2017
BioPortfolio
Theravectys: Theravectys SA Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Mar 08, 2016
in-PharmaTechnologist
Theravectys: HIV vaccine developer Theravectys says GMP suspension at Paris plant won't delay trial
Mar 07, 2016
in-PharmaTechnologist
Theravectys: ANSM bans production at Theravectys' Paris facility until September
Mar 07, 2016
FiercePharmaManufacturing
Theravectys: France's ANSM orders French biotech Theravectys to suspend manufacturing
Theravectys Competitors
1
2
3
4
5
6
7
8
9
10
Looking for similar companies to Theravectys?
Theravectys News
Theravectys Press Releases
Theravectys Videos
Theravectys Headquarters
Theravectys Summary
ABOUT
Overview
Theravectys discovers and develops immunotherapies for the prevention and treatment of cancers and other infectious diseaseses. Theravectys was founded in 2005. Theravectys' headquarters is located in Paris Cedex, Île-de-France, FR 75749. Theravectys...CEO
Theravectys's CEO, Ye Tian, currently has an approval rating of 84%. Theravectys's primary competitors are Inovio, Kite Pharma, Immune Design and 16 more.Website
theravectys.comCompetitors
View 19 Theravectys competitors here.Acquisitions
There have been no acquisitions found related to TheravectysInvestments
Recent investment data cannot be found related to TheravectysFrequently Asked Questions about Theravectys
When was Theravectys founded?
Theravectys was founded in 2005Who is Theravectys's CEO?
Theravectys's CEO is Ye TianHow much revenue does Theravectys generate?
Theravectys generates $15M in revenueHow much funding does Theravectys have?
Theravectys has historically raised $36.9M in funding
Where is Theravectys's headquarters?
Theravectys's headquarters is in Paris Cedex Île-de-France, FRHow many employees does Theravectys have?
Theravectys has 25 employeesWhat sector does Theravectys operate in?
Theravectys is in BiotechnologyWho are Theravectys's competitors?
Theravectys's top competitors are Inovio, Kite Pharma, Immune Design